High Flow Nasal Cannula Weaning in Acute Bronchiolitis
High Flow Nasal Cannula Weaning in Acute Bronchiolitis - an Open-label Randomized Controlled Trials
Kuopio University Hospital
50 participants
Feb 13, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.
Eligibility
Inclusion Criteria5
- Clinically diagnosed acute bronchiolitis
- High flow nasal cannula treatment has lasted for at least 12 hours
- Measured saturation 95 or more with room air
- High flow rate is maximum 2l/kg/min
- The treating doctors considers the infant suitable to be without high flow
Exclusion Criteria3
- Major congenital anomaly of lungs, hearts or diaphragm
- Bacterial pneumonia
- Parents do not give consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
High flow is immediately ended
High flow is gradually weaned by reducing the flow rate
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06321133